[go: up one dir, main page]
More Web Proxy on the site http://driver.im/ Skip to main content

CORRECTION article

Front. Bioinform., 20 July 2022
Sec. Network Bioinformatics
Volume 2 - 2022 | https://doi.org/10.3389/fbinf.2022.974000

Corrigendum: Increased Expression of INHBA Is Correlated With Poor Prognosis and High Immune Infiltrating Level in Breast Cancer

This article is a correction to:

  1. Increased Expression of INHBA Is Correlated With Poor Prognosis and High Immune Infiltrating Level in Breast Cancer

    1. Read original article
Zeying YuZeying Yu1Li ChengLi Cheng2Xinlian LiuXinlian Liu3Lushun ZhangLushun Zhang3Hui Cao Hui Cao3*
  • 1Department of Pathogenic Biology, School of Basic Medical Science, Chengdu Medical College, Chengdu, China
  • 2School of Basic Medical Science, Chengdu Medical College, Chengdu, China
  • 3Department of Pathology and Pathophysiology, School of Basic Medical Science, Chengdu Medical College, Chengdu, China

A Corrigendum on
Increased Expression of INHBA Is Correlated With Poor Prognosis and High Immune Infiltrating Level in Breast Cancer

by Yu Z, Cheng L, Liu X, Zhang L and Cao H (2022). Front. Bioinform. 2:729902. doi: 10.3389/fbinf.2022.729902

In the published article, there was an error in the Funding statement. The funding number for the Research Foundation of Chengdu Medical College was displayed as “No. 16Z141.” The correct number is “No. CYZ16-02.” The correct Funding statement appears below:

“This study was supported by grants from the Research Foundation of Chengdu Medical College (No. CYZ16-02) and Sichuan Science and Technology Foundation (No. 2021YJ0089).”

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher’s Note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Keywords: breast cancer, macrophages, prognosis, INHBA, CAFs

Citation: Yu Z, Cheng L, Liu X, Zhang L and Cao H (2022) Corrigendum: Increased Expression of INHBA Is Correlated With Poor Prognosis and High Immune Infiltrating Level in Breast Cancer. Front. Bioinform. 2:974000. doi: 10.3389/fbinf.2022.974000

Received: 20 June 2022; Accepted: 22 June 2022;
Published: 20 July 2022.

Approved by:

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2022 Yu, Cheng, Liu, Zhang and Cao. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Hui Cao, Y2FvaHVpMTk4ODA5MDdAMTYzLmNvbQ==

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.